USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICAMENTS FOR THE PREVENTION AND THE TREATMENT OF DYSLIPIDEMIA AND ILLNESSES ASSOCIATED WITH DYSLIPIDEMIA AND/OR OBESITY

摘要

The invention relates to the use of an antagonistic compound of cannabinoid receptors CB1, said compound being derived from pyrazole and used alone or associated with another active ingredient, for preparing medicaments for the prevention and treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity, such as the metabolic syndrome, cardiovascular risks and hepatic diseases.